Contact
pdf downloadFull List Download 

Metabolism is the process of making energy from the food. metabolic disease, any of the diseases or disorders that disrupt normal metabolism, the process of converting food to energy on a cellular level. Thousands of enzymes participating in numerous interdependent metabolic pathways carry out this process. Metabolic diseases affect the ability of the cell to perform critical biochemical reactions that involve the processing or transport of proteins (amino acids), carbohydrates (sugars and starches), or lipids (fatty acids). The consequences of metabolic disorder may be severe; intellectual disability, seizures, decreased muscle tone, organ failure, blindness, and deafness may occur, depending on which enzyme is dysfunctional. Biomarker such as -25 hydroxyvitamin D, amino-terminal propeptide (PINP), β-isomerized C-terminal telopeptides, 25-hydroxy (OH) Vitamin, S-adenosylhomocysteine (AdoHcy) hydrolase, cystathionine-β-synthase enzyme, Phospholipase A2, Retinol binding protein 4 and so on are suitable for monitoring metabolic disease. Detecting the quantity of these marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.

Classification: 25-OH-(VD3+VD2) PINP β-CTx 25-OH-VD 25-OH-VD-3 SAHH CBL CBS LP-PLA2 RBP4




25 hydroxyvitamin D (25-OH-(VD3+VD2))

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-SMT-25-OH-VD3/2 Human 25 hydroxyvitamin D (25-OH-(VD3+VD2)) bone fracture, coronary heart disease, cancer, and all-cause mortality GMP-SMT-25-OH-VD3/2-Ag01:
BSA-25 hydroxyvitamin D (25-OH-(VD3+VD2))
GMP-SMT-25-OH-VD3/2-Ag02:
OVA-25 hydroxyvitamin D (25-OH-(VD3+VD2))
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-25 hydroxyvitamin D (25-OH-(VD3+VD2))], 25 hydroxyvitamin D (25-OH-(VD3+VD2)) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in 25-OH-(VD3+VD2) level test of Metabolic diseases (bone fracture, coronary heart disease, cancer, and all-cause mortality) and related syndrome evaluation. GMP-SMT-25-OH-VD3/2-Ab01:
Anti-25 hydroxyvitamin D (25-OH-(VD3+VD2)) mouse monoclonal antibody(mAb)
Human 25 hydroxyvitamin D (25-OH-(VD3+VD2)) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in 25-OH-(VD3+VD2) level test of Metabolic diseases (bone fracture, coronary heart disease, cancer, and all-cause mortality) and related syndrome evaluation. Picture loading failed.



amino-terminal propeptide (PINP) (PINP)

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-h-PINP Human amino-terminal propeptide (PINP) (PINP) osteoporosis therapy GMP-h-PINP-Ag01:
Recombinant human PINP Protein
amino-terminal propeptide (PINP) (PINP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in PINP level test of Metabolic diseases(osteoporosis therapy) and related syndrome evaluation. GMP-h-PINP-Ab01;
GMP-h-PINP-Ab02:
Anti-human PINP mouse monoclonal antibody(mAb)
Human amino-terminal propeptide (PINP) (PINP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other amino-terminal propeptide (PINP) (PINP) antibodies in PINP level test of Metabolic diseases (osteoporosis therapy) and related syndrome evaluation. Picture loading failed.



β-isomerized C-terminal telopeptides (β-CTx)

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-h-β-CTx Human β-isomerized C-terminal telopeptides (β-CTx) osteoporosis GMP-h-β-CTx-Ag01:
Recombinant human β-CTx Protein
β-isomerized C-terminal telopeptides (β-CTx) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in β-CTx level test of Metabolic diseases(osteoporosis) and related syndrome evaluation. GMP-h-β-CTx-Ab01;
GMP-h-β-CTx-Ab02:
Anti-human β-CTx mouse monoclonal antibody(mAb)
Human β-isomerized C-terminal telopeptides (β-CTx) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other β-isomerized C-terminal telopeptides (β-CTx) antibodies in β-CTx level test of Metabolic diseases (osteoporosis) and related syndrome evaluation. Picture loading failed.



25-hydroxy (OH) Vitamin (25-OH-VD)

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-SMT-25-OH-VD Human 25-hydroxy (OH) Vitamin (25-OH-VD) osteoporosis and rickets GMP-SMT-25-OH-VD-Ag01:
BSA-25-hydroxy (OH) Vitamin (25-OH-VD)
GMP-SMT-25-OH-VD-Ag02:
OVA-25-hydroxy (OH) Vitamin (25-OH-VD)
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-25-hydroxy (OH) Vitamin (25-OH-VD)], 25-hydroxy (OH) Vitamin (25-OH-VD) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in 25-OH-VD level test of Metabolic diseases (osteoporosis and rickets) and related syndrome evaluation. GMP-SMT-25-OH-VD-Ab01:
Anti-25-hydroxy (OH) Vitamin (25-OH-VD) mouse monoclonal antibody(mAb)
Human 25-hydroxy (OH) Vitamin (25-OH-VD) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in 25-OH-VD level test of Metabolic diseases (osteoporosis and rickets) and related syndrome evaluation. Picture loading failed.



25-hydroxy (OH) Vitamin (25-OH-VD)

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-SMT-25-OH-VD-3 Human 25-hydroxy (OH) Vitamin D3 (25-OH-VD-3) osteoporosis and rickets GMP-SMT-25-OH-VD-3-Ag01:
BSA-25-hydroxy (OH) Vitamin D3 (25-OH-VD)
GMP-SMT-25-OH-VD-3-Ag02:
OVA-25-hydroxy (OH) Vitamin D3 (25-OH-VD-3)
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-25-hydroxy (OH) Vitamin D3 (25-OH-VD-3)], 25-hydroxy (OH) Vitamin D3 (25-OH-VD-3) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in 25-OH-VD-3 level test of Metabolic diseases (osteoporosis and rickets) and related syndrome evaluation. GMP-SMT-25-OH-VD-3-Ab01;
GMP-SMT-25-OH-VD-3-Ab02:
Anti-25-hydroxy (OH) Vitamin D3 (25-OH-VD-3) mouse monoclonal antibody(mAb)
Human 25-hydroxy (OH) Vitamin D3 (25-OH-VD-3) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in 25-OH-VD-3 level test of Metabolic diseases (osteoporosis and rickets) and related syndrome evaluation. Picture loading failed.



S-adenosylhomocysteine (AdoHcy) hydrolase (SAHH)

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-h-SAHH Human S-adenosylhomocysteine (AdoHcy) hydrolase (SAHH) S-adenosylhomocysteine (AdoHcy) hydrolase deficiency GMP-h-SAHH-Ag01:
Recombinant human SAHH Protein
S-adenosylhomocysteine (AdoHcy) hydrolase (SAHH) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in SAHH level test of Metabolic diseases(S-adenosylhomocysteine (AdoHcy) hydrolase deficiency) and related syndrome evaluation. GMP-h-SAHH-Ab01;
GMP-h-SAHH-Ab02:
Anti-human SAHH mouse monoclonal antibody(mAb)
Human S-adenosylhomocysteine (AdoHcy) hydrolase (SAHH) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other S-adenosylhomocysteine (AdoHcy) hydrolase (SAHH) antibodies in SAHH level test of Metabolic diseases (S-adenosylhomocysteine (AdoHcy) hydrolase deficiency) and related syndrome evaluation. Picture loading failed.



cystathionine-β-synthase enzyme (CBL)

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-h-CBL Human cystathionine-β-synthase enzyme (CBL) ectopia lentis, learning difficulties and skeletal abnormalities GMP-h-CBL-Ag01:
Recombinant human CBL Protein
cystathionine-β-synthase enzyme (CBL) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in CBL level test of Metabolic diseases(ectopia lentis, learning difficulties and skeletal abnormalities) and related syndrome evaluation. GMP-h-CBL-Ab01;
GMP-h-CBL-Ab02:
Anti-human CBL mouse monoclonal antibody(mAb)
Human cystathionine-β-synthase enzyme (CBL) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other cystathionine-β-synthase enzyme (CBL) antibodies in CBL level test of Metabolic diseases (ectopia lentis, learning difficulties and skeletal abnormalities) and related syndrome evaluation. Picture loading failed.



cystathionine-β-synthase enzyme (CBS)

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-h-CBS Human cystathionine-β-synthase enzyme (CBS) ectopia lentis, learning difficulties and skeletal abnormalities GMP-h-CBS-Ag01:
Recombinant human CBS Protein
cystathionine-β-synthase enzyme (CBS) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in CBS level test of Metabolic diseases(ectopia lentis, learning difficulties and skeletal abnormalities) and related syndrome evaluation. GMP-h-CBS-Ab01;
GMP-h-CBS-Ab02:
Anti-human CBS mouse monoclonal antibody(mAb)
Human cystathionine-β-synthase enzyme (CBS) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other cystathionine-β-synthase enzyme (CBS) antibodies in CBS level test of Metabolic diseases (ectopia lentis, learning difficulties and skeletal abnormalities) and related syndrome evaluation. Picture loading failed.



Phospholipase A2 (LP-PLA2)

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-SMT-LP-PLA2 Human Phospholipase A2 (LP-PLA2) atherosclerosis, hyperlipidemia, obesity, and diabetes GMP-SMT-LP-PLA2-Ag01:
BSA-Phospholipase A2 (LP-PLA2)
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Phospholipase A2 (LP-PLA2)], Phospholipase A2 (LP-PLA2) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in LP-PLA2 level test of Metabolic diseases (atherosclerosis, hyperlipidemia, obesity, and diabetes) and related syndrome evaluation. GMP-SMT-LP-PLA2-Ab01;
GMP-SMT-LP-PLA2-Ab02:
Anti-Phospholipase A2 (LP-PLA2) mouse monoclonal antibody(mAb)
Human Phospholipase A2 (LP-PLA2) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in LP-PLA2 level test of Metabolic diseases (atherosclerosis, hyperlipidemia, obesity, and diabetes) and related syndrome evaluation. Picture loading failed.



Retinol binding protein 4 (RBP4)

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-SMT-RBP4 Human Retinol binding protein 4 (RBP4) obesity, type 2 diabetes, metabolic syndrome, and cardiovascular diseases GMP-SMT-RBP4-Ag01:
BSA-Retinol binding protein 4 (RBP4)
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Retinol binding protein 4 (RBP4)], Retinol binding protein 4 (RBP4) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in RBP4 level test of Metabolic diseases (obesity, type 2 diabetes, metabolic syndrome, and cardiovascular diseases) and related syndrome evaluation. GMP-SMT-RBP4-Ab01;
GMP-SMT-RBP4-Ab02:
Anti-Retinol binding protein 4 (RBP4) mouse monoclonal antibody(mAb)
Human Retinol binding protein 4 (RBP4) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in RBP4 level test of Metabolic diseases (obesity, type 2 diabetes, metabolic syndrome, and cardiovascular diseases) and related syndrome evaluation. Picture loading failed.






GENEMEDI
6th Floor, Buiding No.2, Kangxin Road 3377, Shanghai, China
Email: [email protected] [email protected]
Telephone: +86-21-50478399   Fax: 86-21-50478399
Privacy Policy
Chinese Website

Apply for
Free
Sample

Sample FOC application

×